Evidence map›Paper›PMID 40084211›Full record

ArticleFrontiers in public health2025

Development and validation of a questionnaire to measure COVID-19 vaccine hesitancy within the Romanian industrial laborers.

Adina Turcu-Stiolica, Ancuta Ramona Boicea, Florina Nechita, Roxana Surugiu, Gheorghe Gindrovel Dumitra, Carmen Nicoleta Oancea, Mihail Cristian Pîrlog

Abstract readValidation Study
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Adina Turcu-Stiolica *Department of Pharmacoeconomics, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Ancuta Ramona Boicea *Department of Occupational Medicine, University of Medicine, and Pharmacy of Craiova, Craiova, Romania.
Florina NechitaDepartment of Medical Psychology, University of Medicine, and Pharmacy of Craiova, Craiova, Romania.
Roxana SurugiuDepartment of Biochemistry, University of Medicine, and Pharmacy of Craiova, Craiova, Romania.
Gheorghe Gindrovel DumitraDepartment of Family Medicine, University of Medicine, and Pharmacy of Craiova, Craiova, Romania.
Carmen Nicoleta OanceaDepartment of Biochemistry, University of Medicine, and Pharmacy of Craiova, Craiova, Romania.
Mihail Cristian PîrlogDepartment of Medical Sociology, University of Medicine, and Pharmacy of Craiova, Craiova, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identification and quantification of sources of vaccine hesitancy among industrial workers in Romania have become crucial for developing effective strategies to facilitate the vaccination process. Our study included employees, both with and without comorbidities, who work in industrial companies. The goal was to develop a scale to assess COVID-19 vaccine hesitancy in Romania. This proposed scale has been designated as the Romanian COVID-19 Vaccine Hesitancy (RO-CVH) scale. The survey encompassed both the demographic characteristics of the respondents and questions related to their perceptions of COVID-19 vaccination. A three-stage process was used to develop the RO-CVH which includes (1) item generation; (2) item-refinement (pilot testing, exploratory factor analysis); and (3) scale validation. The fifteen items loaded onto three factors using exploratory factor analysis, explaining 63% of the total variance. The three factors were labelled as "Confidence in information regarding the COVID-19 vaccine," "Safety and efficacy of the COVID-19 vaccine," and "COVID-19 vaccination as a means of controlling the population." The content validity of the scale was established, and it will be utilized to comprehend the behavior of industrial workers in Romania during similar future outbreaks, particularly regarding the acceptance of mitigatory vaccines. Based on the insights from this scale, future interventions could be designed to reduce vaccine hesitancy.

Indexed as

COVID-19COVID-19 VaccinesIndustryVaccination HesitancyAdultFemaleHumansMaleMiddle AgedReproducibility of ResultsRomaniaSARS-CoV-2Surveys and QuestionnairesCOVID-19 VaccinesCOVID-19COVID-19 vaccinationCOVID-19 vaccinequestionnaireRomaniavaccine hesitancy

Identifiers

PMID40084211
PMCPMC11903443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.